Filing Details

Accession Number:
0001469709-19-000006
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-02-04 17:22:42
Reporting Period:
2019-01-15
Accepted Time:
2019-02-04 17:22:42
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1085596 Angiogenex Inc. AGGX Pharmaceutical Preparations (2834) 860945116
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1728637 Michael Aronstein 425 Madison Ave.
Suite 902
New York NY 10017
Yes No Yes Yes
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-01-15 1,000,000 $0.20 3,500,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 2,000,000 Indirect By MCA Family Trust
Footnotes
  1. The reporting person serves as a co-trustee of the MCA Family Trust.